FOR IMMEDIATE RELEASE:
PAIN RELIEVING PATCH WITH MORE MEDICINE, LARGER SIZE AND PEEL
RESISTANT
FLORHAM PARK, NJ; February 4th 2016 –Hisamitsu America, a division of Hisamitsu
Pharmaceutical Co., Inc., and the manufacturers of Salonpas®
,
The one and only OTCpain patch that is FDA approved and clinically proven, maintains their commitment toproviding industry leading, topical analgesic solutions with the launch of the newSalonpas®
Pain Relieving Patch. The new latex-free Salonpas®Pain Relieving
Patch (MSRP: $10.99), featuring beige stretchable fabric with rounder corners, includes
60 larger size patches, enhanced adhesion, peel resistance and improved
effectiveness.
“We developed this new Pain Relieving Patch to improve the patch user’s experience
while maintaining great value,” said John Incledon, President & CEO, Hisamitsu
America. “These patches are 20% larger than the original patches and allow for quicker
skin permeation of Methyl Salicylate which is an important performance factor in
reducing pain quickly.”
The new Salonpas®Pain Relieving Patch is available at leading retailers nationwide.
This convenient and versatile patch includes three active ingredients, camphor (3.1%),
menthol (10%) and methyl salicylate (15%), which provides temporary relief of minor
aches and pains.
About Hisamitsu America:
Hisamitsu America is the US division of Hisamitsu Pharmaceutical Co., Inc., founded in
1847, which has specialized in topical drug delivery technology since the introduction of
its Salonpas line of patches in 1934. The SALONPAS®product line, which gained early
acceptance in Asia and now sells in 50 countries, has pioneered the development of
topicalpatches to relieve everyday aches and pains. Today, the Salonpas® Pain Relief
Patches are the first and only FDA-approved OTC pain patch. For more information,
visit www.salonpas.us.
PAIN RELIEVING PATCH WITH MORE MEDICINE, LARGER SIZE AND PEEL
RESISTANT
FLORHAM PARK, NJ; February 4th 2016 –Hisamitsu America, a division of Hisamitsu
Pharmaceutical Co., Inc., and the manufacturers of Salonpas®
,
The one and only OTCpain patch that is FDA approved and clinically proven, maintains their commitment toproviding industry leading, topical analgesic solutions with the launch of the newSalonpas®
Pain Relieving Patch. The new latex-free Salonpas®Pain Relieving
Patch (MSRP: $10.99), featuring beige stretchable fabric with rounder corners, includes
60 larger size patches, enhanced adhesion, peel resistance and improved
effectiveness.
“We developed this new Pain Relieving Patch to improve the patch user’s experience
while maintaining great value,” said John Incledon, President & CEO, Hisamitsu
America. “These patches are 20% larger than the original patches and allow for quicker
skin permeation of Methyl Salicylate which is an important performance factor in
reducing pain quickly.”
The new Salonpas®Pain Relieving Patch is available at leading retailers nationwide.
This convenient and versatile patch includes three active ingredients, camphor (3.1%),
menthol (10%) and methyl salicylate (15%), which provides temporary relief of minor
aches and pains.
About Hisamitsu America:
Hisamitsu America is the US division of Hisamitsu Pharmaceutical Co., Inc., founded in
1847, which has specialized in topical drug delivery technology since the introduction of
its Salonpas line of patches in 1934. The SALONPAS®product line, which gained early
acceptance in Asia and now sells in 50 countries, has pioneered the development of
topicalpatches to relieve everyday aches and pains. Today, the Salonpas® Pain Relief
Patches are the first and only FDA-approved OTC pain patch. For more information,
visit www.salonpas.us.